Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GERON CORPGERN · Entity 4989 | EVP, Chief Legal Officer | February 27, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GERON CORP
Report date February 27, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,682 |
Reported balance
After 2025-02-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-02-27 · Purchase · Acquired 15,000 · Balance 26,682 F1: The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share. F2: The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share.
F2: The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2025 Filed Mar 3, 2025 11:01 UTC | GERON CORP GERN · Entity 4989 | PurchaseCommon Stock | 15,000 | $1.61 | $24,150.00 |
DisclosureSEC source: 0000950170-25-030330 · ownership.xml · nonDerivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,682 F1 · kind: The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share. F2 · balance_after: The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | GERON CORP GERN · Entity 4989 | GrantRestricted Stock Units · Derivative | 104,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024131 · ownership.xml · derivative · entry 2 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | GERON CORP GERN · Entity 4989 | GrantStock Option (right to buy) · Derivative | 621,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024131 · ownership.xml · derivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,000 Underlying: Common Stock · 621,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:10 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0000950170-24-070624 · ownership.xml · derivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-07-31 F1 · derivative.exercise_date: Performance-based stock option granted on August 1, 2023 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:09 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 850,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001415889-24-004097 · form4-02162024_090225.xml · derivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP & CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 850,000 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 14, 2024, provided the optionee continues to provide service to the Company. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 22:02 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 1,350,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001062993-23-015795 · form4.xml · derivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,350,000 Underlying: Common Stock · 1,350,000 shares Expires 2033-07-31 F1 · derivative.exercise_date: This option vests as follows:168,750 shares on February 1, 2024, the remaining 1,181,250 shares in a series of 42 equal monthly installments commencing February 1, 2024, provided the optionee continues to provide services to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.